Skip to content

Clinical trials

Withdrawn Observational Leukemia, Lymphocytic, Chronic, B-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Observational Status: Withdrawn Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20082
20101
20131
20142
20151
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abramson Cancer Center at Penn Medicine1
Dana-Farber Cancer Institute1
Dartmouth-Hitchcock Medical Center1
Janssen Pharmaceutica1
Maastricht Radiation Oncology1
Mayo Clinic1
Memorial Sloan Kettering Cancer Center1
Rutgers, The State University of New Jersey1
University of Medicine and Dentistry of New Jersey1
Wake Forest University Health Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell10
Lymphoma, Non-Hodgkin4
Multiple Myeloma4
Burkitt Lymphoma3
Congenital Abnormalities3
Hodgkin Disease3
Leukemia3
Leukemia, Hairy Cell3
Leukemia, Myeloid, Acute3
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative3

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.